Thrombotic thrombocytopenic purpura as the first manifestation of metastatic adenocarcinoma in a young woman.

[1]  M. Zupancic,et al.  Gemcitabine-associated thrombotic thrombocytopenic purpura. , 2007, The Lancet. Oncology.

[2]  R. Young,et al.  From Krukenberg to Today: The Ever Present Problems Posed by Metastatic Tumors in the Ovary. Part II , 2007, Advances in anatomic pathology.

[3]  G. Rodgers,et al.  Management of cancer‐associated thrombotic microangiopathy: What is the right approach? , 2007, American journal of hematology.

[4]  S. Vesely,et al.  Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases. , 2006, The oncologist.

[5]  R. Young,et al.  From Krukenberg to Today: The Ever Present Problems Posed by Metastatic Tumors in the Ovary: Part I. Historical Perspective, General Principles, Mucinous Tumors Including the Krukenberg Tumor , 2006, Advances in anatomic pathology.

[6]  J. George,et al.  Clinical practice. Thrombotic thrombocytopenic purpura. , 2006, The New England journal of medicine.

[7]  B. Lämmle,et al.  Treatment of thrombotic thrombocytopenic purpura , 1983, Vox sanguinis.

[8]  J. Kiss,et al.  Thrombotic microangiopathy in transplantation and malignancy. , 2005, Seminars in thrombosis and hemostasis.

[9]  A. Walker,et al.  Incidence of Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome , 2004, Epidemiology.

[10]  J. Moake.  von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura. , 2004, Seminars in hematology.

[11]  H. Wada,et al.  The Japanese experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. , 2004, Seminars in hematology.

[12]  Jae C Chang,et al.  Thrombotic thrombocytopenic purpura associated with bone marrow metastasis and secondary myelofibrosis in cancer. , 2003, The oncologist.

[13]  B. Lämmle,et al.  Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience 2001/2002 of a single research laboratory. , 2003, Swiss medical weekly.

[14]  J. Moake,et al.  Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. , 2000, Current opinion in pediatrics.

[15]  J. M. Rodríguez,et al.  Thrombotic thrombocytopenic purpura and bone marrow necrosis as a complication of gastric neoplasm. , 2002, Haematologica.

[16]  M. Elliott,et al.  Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. , 2001, Mayo Clinic proceedings.

[17]  L. Gordon,et al.  Thrombotic Microangiopathy in the Cancer Patient , 2001, Acta Haematologica.

[18]  E. Gabazza,et al.  Increased Plasma Thrombomodulin as a Vascular Endothelial Cell Marker in Patients With Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome , 2001, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[19]  C. Peschel,et al.  Thrombotic thrombocytopenic purpura in metastatic carcinoma of the breast. , 2000, American Journal of Clinical Oncology.

[20]  E. Lian,et al.  Plasma from a patient with thrombotic thrombocytopenic purpura induces endothelial cell apoptosis and platelet aggregation. , 1999, Thrombosis research.

[21]  J. George,et al.  Plasminogen activator inhibitor (PAI‐1) antigen levels in primary TTP and secondary TTP post‐bone marrow transplantation , 1998, American journal of hematology.

[22]  Jonathan S. Berek,et al.  Novak's Gynecology , 1996 .

[23]  R. Hoffman,et al.  Hematology: Basic Principles and Practice , 1995 .

[24]  H. Shiku,et al.  Decreased Plasma Tissue Factor Pathway Inhibitor Levels in Patients with Thrombotic Thrombocytopenic Purpura , 1995, Thrombosis and Haemostasis.

[25]  R. L. Peugeot,et al.  Treatment of cancer chemotherapy‐associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma , 1993, Cancer.

[26]  P. Woolley,et al.  Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  Hrozencik Sp,et al.  Cancer-associated hemolytic uremic syndrome. , 1988 .

[28]  R. Mayer,et al.  Microangiopathic Hemolytic Anemia and Cancer: A Review , 1979, Medicine.

[29]  D. Sloan.  Pelvic pain and dysmenorrhea. , 1972, Pediatric clinics of North America.